All stock lists
Agenus Inc (NASDAQ:AGEN)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
6.20-0.13 (-2.05%)
Insider Score
––Not scored
AGEN Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
AGEN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 34.52 M | 33.74 M | 34.20 M | 30.23 M | 25.69 M | 24.07 M |
| Revenue Growth (YoY) | 34.36 % | 40.18 % | 27.45 % | 20.40 % | 9.28 % | -14.07 % |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 642.00 K | 243.00 K | 137.00 K |
| Gross Profit | 34.52 M | 33.74 M | 34.20 M | 29.59 M | 25.45 M | 23.93 M |
| SG&A Expense | 8.47 M | 6.86 M | 12.29 M | 10.86 M | 15.52 M | 15.72 M |
| R&D Expense | 14.76 M | 11.82 M | 7.51 M | 23.60 M | 26.71 M | 21.52 M |
| Operating Expenses | 23.23 M | 18.68 M | 19.81 M | 34.14 M | 42.16 M | 37.24 M |
| Operating Income | 11.29 M | 15.05 M | 14.40 M | -4.54 M | -16.71 M | -13.31 M |
| Pretax Income | -567.00 K | 39.21 M | -10.61 M | 63.91 M | -30.01 M | -26.37 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -550.00 K | 39.23 M | -10.58 M | 63.91 M | -27.95 M | -25.27 M |
| EPS (Basic) | -0.01 | 1.03 | -0.30 | 2.00 | -1.00 | -1.03 |
| EPS (Diluted) | -0.01 | 1.02 | -0.30 | 1.94 | -1.00 | -1.03 |
| Shares Outstanding | 41.34 M | 37.94 M | 29.73 M | 31.89 M | 28.12 M | 24.47 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.